Selumetinib and Azacitidine in High Risk Chronic Blood Cancers
Condition(s):Chronic Myeloid Leukemia; MyelofibrosesLast Updated:January 29, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Chronic Myeloid Leukemia; MyelofibrosesLast Updated:January 29, 2024Recruiting
Condition(s):Neurofibromatosis Type 1; Plexiform Neurofibroma; Optic Nerve GliomaLast Updated:February 24, 2023Recruiting
Condition(s):Neurofibromatosis Type 1Last Updated:February 8, 2024Recruiting
Condition(s):Neurofibromatosis 1; Plexiform NeurofibromaLast Updated:March 15, 2024Not yet recruiting
Condition(s):MPNST; NF1; SarcomaLast Updated:January 9, 2024Not yet recruiting
Condition(s):Recurrent Low Grade Astrocytoma; Recurrent WHO Grade 2 Glioma; Refractory Low Grade Astrocytoma; Refractory Low Grade Glioma; Refractory WHO Grade 1 GliomaLast Updated:March 27, 2024Recruiting
Condition(s):NeurofibromaLast Updated:March 22, 2024Recruiting
Condition(s):Recurrent Endometrial Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal CarcinomaLast Updated:March 28, 2024Recruiting
Condition(s):Low Grade Glioma; Neurofibromatosis Type 1; Visual Pathway GliomaLast Updated:March 27, 2024Recruiting
Condition(s):Low Grade Astrocytoma; Low Grade Glioma; Metastatic Low Grade Astrocytoma; Metastatic Low Grade GliomaLast Updated:March 26, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.